Skip to main content

Table 3 Prevalence of HBsAg and HCV by country.

From: Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation

    TTI prevalence
Country Reference Year HBsAg Anti HCv
Botswana [2] 2004 0.05 NA
South Africa [2] 2004 0.05 NA
Kenya [2] 2004 0.042 NA
  [39] 1999 0.039 0.018
Tanzania [40] 2006 0.048 NA
  [41] 2006 0.088 0.015
  [42] 2007 0.053 0.055
  1. NA: not available